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REPORT
A brain-based pain facilitation mechanism
contributes to painful diabetic polyneuropathy
Andrew R. Segerdahl,1 Andreas C. Themistocleous,2 Dean Fido,1 David L. Bennett2 and
Irene Tracey1
The descending pain modulatory system represents one of the oldest and most fundamentally important neurophysiological
mechanisms relevant to pain. Extensive work in animals and humans has shown how a functional imbalance between the facili-
tatory and inhibitory components is linked to exacerbation and maintenance of persistent pain states. Forward translation of these
ﬁndings into clinical populations is needed to verify the relevance of this imbalance. Diabetic polyneuropathy is one of the most
common causes of chronic neuropathic pain; however, the reason why 25–30% of patients with diabetes develop pain is not
known. The current study used a multimodal clinical neuroimaging approach to interrogate whether the sensory phenotype of
painful diabetic polyneuropathy involves altered function of the ventrolateral periaqueductal grey—a key node of the descending
pain modulatory system. We found that ventrolateral periaqueductal grey functional connectivity is altered in patients suffering
from painful diabetic polyneuropathy; the magnitude of which is correlated to their spontaneous and allodynic pain as well as the
magnitude of the cortical response elicited by an experimental tonic heat paradigm. We posit that ventrolateral periaqueductal
grey-mediated descending pain modulatory system dysfunction may reﬂect a brain-based pain facilitation mechanism contributing
to painful diabetic polyneuropathy.
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Introduction
Chronic pain is one of the largest and costliest medical
health problems in the developed world and it is likely to
worsen (Gaskin and Richard, 2012; Fayaz et al., 2016).
Diabetic polyneuropathy (DPN) is a major factor contribut-
ing to this increase: the global prevalence of diabetes melli-
tus is inexorably rising, 30–50% of such patients develop
DPN and up to 50% of these will develop neuropathic
pain, which is currently inadequately treated (Feldman
et al., 2017).
We need to interrogate what the underlying neurophysio-
logical mechanisms are that precipitate and maintain
chronic pain (Tracey, 2017). Extensive work in preclinical
animal models highlights the importance of the descending
pain modulatory system (DPMS) in chronic pain states
(DeFelice et al., 2011; Wang et al., 2013). The DPMS is
deﬁned as a brainstem–subcortical–cortical network that
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can modulate nociceptive input to the brain—either by
amplifying or attenuating afferent nociceptive input at the
dorsal horn of the spinal cord (Basbaum and Fields, 1978;
Fields, 1992; Gebhart, 2004; Mason, 2012). As such, the
functional balance between inhibitory and facilitatory arms
of this network powerfully controls the resultant afferent
nociceptive volley to the brain and hence the resultant pain
experience. A primary hypothesis that has emerged from
this literature is that persistent pain is linked to an imbal-
ance in DPMS function—either due to a diminished inhibi-
tory and/or an enhanced facilitatory capacity of the DPMS
(Keay and Bandler, 2002; Lumb et al., 2002, 2004; Porreca
et al., 2002; Suzuki et al., 2004; Heinricher et al., 2009;
DeFelice et al., 2011; Wang et al., 2013).
In humans, neuroimaging studies of central sensitization
in either experimental medicine models or patients conﬁrm
that key nuclei of the DPMS play fundamental roles in the
maintenance of central sensitization pain, mechanical
hyperalgesia and mechanical allodynia (Iannetti et al.,
2005; Zambreanu et al., 2005; Mainero et al., 2007; Lee
et al., 2008).
Forward translation of these ﬁndings into different pa-
tient groups is starting to emerge, as is evidence supporting
the possible role of brainstem-mediated facilitation under-
lying different features of clinical pain (Gwilym et al.,
2009; Schwedt et al., 2014; Yu et al., 2014; Soni et al.,
2016; Truini et al., 2016).
While these studies have shown a link between DPMS
dysfunction and clinical measures of pain, the precise mech-
anism by which the DPMS contributes to pain facilitation
in chronic pain is unclear.
We hypothesized that the sensory phenotype of DPN pa-
tients with pain (NP+ ) involves altered connectivity of the
ventrolateral periacqueductal grey (vlPAG)—a vital nucleus
within the DPMS—to key pain processing brain regions.
Further, that the extent to which it is connected is related
to key features of their pain: namely, the intensity of their
spontaneous background pain and their brain response and
pain intensity rating to a tonic heat hyperalgesia challenge.
We interrogated this in DPN patients who were meticu-
lously well matched for key clinical markers of disease pro-
gression but within whom only a percentage suffer from
persistent neuropathic pain (Themistocleous et al., 2016).
We posit that the altered vlPAG functional connectivity
proﬁle in NP+ patients may reﬂect a brain-based pain fa-
cilitation mechanism underlying this notoriously debilitat-
ing disease.
Materials and methods
Participants
Thirty individuals were recruited from the Pain in Neuropathy
Study (PiNS, approved by the National Research Ethics
Service, UK: No: 10/H07056/35), and written informed con-
sent was obtained according to the Declaration of Helsinki.
Refer to Themistocleous et al. (2016) for a detailed description
of PiNS. Data from two participants were excluded because of
scanner-related problems and a further two participants were
excluded because of illness during scanning.
Sensory phenotyping
The participants were studied intensively using a range of clin-
ical, neuroimaging and behavioural tests. Basic clinical param-
eters were measured for each participant (weight, height, and
blood pressure) (Supplementary Table 1). A structured neuro-
logical examination including assessment of nerve conduction,
skin biopsy and quantitative sensory testing (QST) were com-
pleted. Additional drug, laboratory, and clinical investigation
data from the clinical records were also collected. All study
participants had diabetes mellitus with evidence of clinical
length-dependant neuropathy conﬁrmed by abnormalities on
either nerve conduction studies or intra-epidermal nerve ﬁbre
density (IEFND) (Tesfaye et al., 2011). The presence of a dia-
betic peripheral neuropathy was conﬁrmed using the compre-
hensive upper and lower limb neurological examination, nerve
conduction testing, determination of IEFND from skin biop-
sies, and the battery of QST measures. Further details can be
found in the Supplementary material and in Themistocleous
et al. (2016). All participants met the American or the
Toronto consensus criteria for a deﬁnite diabetic peripheral
neuropathy.
Painful versus painless diabetic
polyneuropathy
The presence of chronic neuropathic pain caused by peripheral
DPN was determined at the time of the clinical assessment and
was in line with the International Association for the Study of
Pain (IASP) deﬁnition of neuropathic pain i.e. ‘pain caused by
a lesion or disease of the somatosensory system’. The IASP/
NeuPSIG grading system was used to grade the neuropathic
pain (Finnerup et al., 2016). Participants were divided into
those with NP+ (painful diabetic neuropathy) and those with-
out, non-NP (painless diabetic neuropathy). Only study par-
ticipants with chronic painful diabetic neuropathy present for
at least 3 months were included in the NP+ group. Study
participants with non-neuropathic pain in the extremities,
such as musculoskeletal pain of the ankle, were included in
the non-NP group. A battery of questionnaires was used to
quantify and monitor features of the NP+ pain; including: the
7-day pain intensity diary, Douleur Neuropathique en 4
Questions (DN4); PainDETECT; Brief Pain Inventory (BPI);
and the Neuropathic Pain Symptom Inventory (NPSI). A de-
tailed description of the questionnaires can be found in the
Supplementary material and in Themistocleous et al. (2016).
SPSS Statistics Version 21 (IBM), GraphPad Prism, and JASP
were used for all statistical analyses. QST z-score data were
expressed as mean  95% conﬁdence interval (CI). All other
data were not normally distributed and reported as the median
with interquartile range (IQR). QST z-scores were compared
with unpaired t-tests and all other data with Mann-Whitney
U-tests. Categorical data were analysed with Fischer’s exact
test. Signiﬁcance was set at P = 0.05.
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Functional MRI
All participants were scanned using a Siemens 3 T Verio
whole-body magnetic resonance scanner equipped with a 32-
channel head and a body coil. T1-weighted structural images
were acquired with a 3D MPRAGE sequence (1  1  1mm
voxels). Five minutes of T2*-weighted blood oxygen level-de-
pendent (BOLD) ‘resting state’ data were acquired using a
multi-band (version 6) sequence (repetition time = 1.3 s; echo
time = 40ms; 2  2  2mm voxels; 72 slices). Subjects were
asked to remain still with their gaze focused on a stationary
visual cue. Absolute cerebral blood ﬂow (CBF) data were
acquired using a multi-inversion time pseudo-continuous arter-
ial spin labelling (pCASL) sequence described previously
(Segerdahl et al., 2015). A total of 114 volumes were acquired
(7min of scan time) for each condition. A full description of
the sequence parameters used are in the Supplementary mater-
ial. Brieﬂy, ‘tag’ and ‘control’ images were acquired every repe-
tition time = 4 s with a label duration of 1.4 s. A total of six
inversion times were used. B0 shimming was performed over
the imaging region and the labelling plane to minimize off-
resonance effects. All participants were scanned at rest
(7min) and then during the experience of tonic heating of
the subject’s feet using a temperature controlled water bottle
(temperature = 44C; as measured throughout scans using an
infrared thermometer). Participants verbally rated the intensity
of their background pain at rest and during the tonic heat
stimulation paradigm using a 0–10 scale. Ratings were col-
lected immediately preceding the start and following the end
of each scan. A schematic of the scan paradigm is displayed in
Fig. 2A.
Functional MRI statistical analysis
MRI data acquisition, preprocessing and analyses followed
standard procedures (Smith et al., 2004). All functional MRI
analysis was completed in each subject’s native anatomical
space and then was co-registered to a standard MNI152 tem-
plate brain using non-linear registration (FNIRT).
BOLD functional data were preprocessed using FSL
FMRIB’s expert analysis tool (FEAT, version 6.0), using a
kernel of full-width at half-maximum of 2mm for spatial
smoothing. Voxel-wise seed-based functional connectivity
analyses were completed using standard methods (Fox
et al., 2006). The seed was deﬁned by a 7 T anatomical
mask for the vlPAG published previously (Ezra et al., 2015;
Faull and Pattinson, 2017); warped to standard 3 T space
(2mm isotropic) using FNIRT and then visually inspected
for accuracy. Nuisance regions of interest for CSF and
white matter were generated for each subject. The ﬁrst
Eigen time series of the seed and regions of interest were
calculated; which is the single time series that best reﬂects
coherent activity across the mask by reﬂecting the largest
amount of total variance that constitutes that mask.
Conditional correlations between the seed and each voxel
in each subject’s brain volume were calculated by regressing
out the Eigen time series of each nuisance region of interest.
This produces a set of partial correlation coefﬁcients for the
seed relative to the whole brain that are not shared by the
nuisance regions of interest. The conditional correlation co-
efﬁcients for each subject’s seed were entered into an un-
paired t-test at the group level alongside a regressor for all
subjects’ background pain ratings (mixed effects; z4 3.1,
P5 0.05).
ASL functional data were preprocessed using previously pub-
lished methods that adhere to current guidelines (Alsop et al.,
2015; Segerdahl et al., 2015). Refer to the Supplementary ma-
terial for more details. The absolute CBF time series generated
for each subject during rest and during tonic heating was aver-
aged using a mixed effects model (to account for voxel-wise
Figure 1 Neuropathic pain severity. (A) Heat maps summar-
ize the mean pain intensity and pain location on the body as gen-
erated from each participant’s 7-day pain diary. Diabetes-associated
neuropathic pain is shown in red and non-neuropathic pain is in grey
for both groups. (B) Scatter plot and mean  95% CI of z-scores for
QST parameters for each group (NP + : blue; non-NP: grey). The z-
score indicates the number of standard deviations the participant
data are from the mean of the control population (i.e. the normative
data). A z-score that lies between 2 and + 2 is considered within
the normal reference range. Positive z-scores denote gain of func-
tion, whereas negative z-scores denote loss of function. CDT = cold
detection threshold; CPT = cold pain threshold; HPT = heat pain
threshold; MDT = mechanical detection threshold; MPS = mechan-
ical pain sensitivity; MPT = mechanical pain threshold; PPT = pres-
sure pain threshold; TSL = thermal sensory limen; VDT = vibration
detection threshold; WDT = warm detection threshold; WUR =
wind-up ratio.
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variance of the Bayesian ﬁt during CBF quantiﬁcation). This
generated a single whole brain voxel-wise absolute CBF
volume for each subject at each condition with a correspond-
ing variance image for use at the group level. Each subject’s
whole brain absolute CBF volume during ‘rest’ and ‘heat’ con-
ditions were used at the group level to determine the group
difference (NP+ 4non-NP) in heat-evoked perfusion as a
function of each subject’s resting vlPAG functional connectiv-
ity strength with the rostral anterior cingulate cortex (rACC)
as observed with the BOLD sequence (Fig. 4A: mixed effects;
z43.1, P5 0.05). The rACC was chosen because it was
observed to have the peak maximum functional connectivity
strength with the vlPAG (Fig. 2), it has connections with the
PAG, and top-down facilitation of pain via this pathway has
been shown previously in rodents (Calejesan et al., 2000;
Porreca et al., 2002). Additionally, a linear correlation be-
tween the vlPAG functional connectivity strength and the
tonic-heat evoked pain intensity ratings was tested for each
group.
Results
Demographics, diabetic
polyneuropathy sensory
phenotype and pain severity
No signiﬁcant differences in age, diabetic control (HbA1c),
gender, ethnicity, body mass index, and waist-hip circumfer-
ence were observed between the groups (Fischer’s exact test;
*P50.05; Supplementary Table 1). Figure 1A shows the dis-
tribution and mean intensity (0–100 scale) of the pain asso-
ciated with NP+ (red) and non-NP (grey) using the 7-day
pain diary. Both groups were well matched across almost all
QST parameters tested and no signiﬁcant differences were
observed between the groups (Fig. 1B). The NP+ participants
scored signiﬁcantly higher onboth the neuropathic andpsycho-
logical screening tools (Mann-Whitney U-tests, P5 0.05;
Figure 2 Experimental pain psychophysics. (A) A schematic summarizing the experimental design of the study. Patients’ sensory phenotype
were confirmed during a clinical examination, which occurred on a separate day that preceded the functional MRI session. The functional MRI session
consisted of three different scans: Scan 1 = high-resolution structural and calibration scans; Scan 2 = BOLD functional MRI resting state data were
acquired; Scan 3 = ASL functional MRI data were acquired during evoked tonic heat applied to the subjects’ feet. Each scan is represented visually by a
different colour. Verbal pain intensity ratings were obtained immediately before and after each scan using the 11-point numerical rating scale (0 = no
pain; 10 = worst pain imaginable). Ratings were collected between scan data collection (i.e. the scanner was ‘off’ during this time). (B) The comparison
of the group mean pain intensity ratings collected at rest (i.e. Scan 2) and during tonic heating (i.e. Scan 3) between NP + and non-NP participants
(Mann-Whitney U-test, Rest: *P = 0.001; Heat: **P = 0.025). Error bars represent the standard deviation of the mean. FMRI = functional MRI.
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Supplementary material). The group mean pain intensity rat-
ings at rest (Scan 2) and during tonic heat stimulation (Scan 3)
are shown in Fig. 2B. NP+ participants reported signiﬁcantly
greater pain for both conditions (Mann-Whitney U-test; Rest:
P = 0.001; Heat: P = 0.025).
Enhanced ventrolateral
periaqueductal grey functional
connectivity in NP+ versus non-NP
There was a signiﬁcant interaction between pain intensity rat-
ings at rest and the vlPAG functional connectivity with the
whole brain between the two groups (Fig. 3A; mixed effects;
z4 3.1, P5 0.05 cluster corrected). Regions that showed an
enhanced connectivity with the seed as a correlate of the inten-
sity of the background spontaneous pain reported included:
bilateral thalamus and cerebellum; the right hypothalamus
and primary somatosensory cortex (SI); and the left amygdala,
nucleus accumbens (NAc), caudate and rACC.
Ventrolateral periaqueductal grey
connectivity predicts heat
hyperalgesia
Figure 4B plots the correlation between the verbal pain
intensity ratings during tonic heat stimulation and the
Figure 3 Enhanced vlPAG functional connectivity in NP+ . (A) Group comparison (NP + 4 Non-NP) of whole brain functional
connectivity strength with the vlPAG seed (from Scan 2) as a function of the background (i.e. ‘resting’) pain intensity ratings (from Scan 2). Voxels
within which this relationship was greater in the NP + group are in red (n = 26; mixed effects: z4 3.1, P5 0.05 cluster corrected). The axial slices
show the extent of activation across the whole brain. Radiological convention is used. (B) For clarity, a plot of the correlation between the
magnitude of vlPAG functional connectivity and the intensity of the pain at rest reported by NP + participants is displayed.
PAG facilitation in painful DPN BRAIN 2018: 141; 357–364 | 361
Downloaded from https://academic.oup.com/brain/article-abstract/141/2/357/4810409
by guest
on 26 March 2018
strength of the vlPAG-rACC functional connectivity pre-
tonic heat stimulation for both NP+ (blue) and non-NP
(grey) patients. In NP+ patients, this correlation was posi-
tive (r = 0.531, P = 0.038); while in non-NP patients no
relationship was observed (r = 0.228; P = 0.50). Further, a
direct comparison between the groups shows this difference
in correlation is signiﬁcant (Fischer r-to-z transformation;
*P5 0.01). Regions within which the correlation between
the tonic heat-induced hyperperfusion and the strength of
the resting vlPAG–rACC functional connectivity was
greater in NP+ versus non-NP patients is displayed in
Fig. 4C (mixed effects; z4 3.1, P5 0.05; cluster corrected).
Regions showing this effect include: bilateral secondary
somatosensory cortex (SII), posterior insula and cerebellum;
the left dorsal posterior insula (dpIns); and the right hippo-
campus, mid-insula and amygdala.
Discussion
Using a multi-modal imaging approach, these data show
that the vlPAG functional connectivity is altered in NP+
versus non-NP DPN patients; and that the extent to which
it is altered is linked to different features of their pain
Figure 4 vlPAG functional connectivity predicts heat hyperalgesia. (A) A schematic of the analysis workflow used to test the rela-
tionship between the functional connectivity (F.C.) strength of the vlPAG-rACC (acquired in Scan 2) and the patients’ behavioural (B) and brain
(C) responses to evoked tonic heat applied to their feet (acquired in Scan 3). (B) A linear correlation between resting vlPAG-rACC functional
connectivity strength (from Scan 2) and the intensity of the pain reported during evoked tonic heat applied to the participants’ feet (from Scan 3;
NP + : blue; non-NP: grey). (C) Tonic-heat induced hyper-perfusion (CBF; acquired in Scan 3) as a function of resting vlPAG-rACC functional
connectivity (acquired during Scan 2). Regions within which the correlation between tonic heat induced changes in CBF and vlPAG-rACC
connectivity strength were greater in NP + versus non-NP patients are shown in red (n = 26, mixed effects, z4 3.1, P5 0.05 cluster corrected).
The axial slices show the extent of activation across the whole brain. Radiological convention is used. FMRI = functional MRI.
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behaviour and the magnitude of the cortical response eli-
cited by an experimental tonic heat paradigm. While the
link between the vlPAG connectivity strength and the pa-
tient’s pain behaviour offers support to the idea that there
is PAG-mediated ampliﬁcation of the NP+ patients pain,
an essential further line of evidence for a brain-based facili-
tation mechanism comes from the difference in tonic heat-
evoked CBF responses between the two groups. These data
show that the vlPAG-rACC connectivity strength is also
positively correlated with the magnitude of the tonic heat-
induced CBF response in the NP+ 4 non-NP patients.
Thus, only in the NP+ patient group is the altered
vlPAG function linked to both the behavioural and brain
responses to heat hyperalgesia.
A key feature of the DPMS is that it is possible to modify
the magnitude of nociceptive input arriving at the cortex at
the level the dorsal horn of the spinal cord; consequently,
an alteration in this capacity may lead to a change in the
pain experienced simply because the nociceptive barrage
arriving in the brain is different. Because the current
study did not have access to a reliable simultaneous
spinal-brain functional MRI method, we don’t know if
there are differences between the groups in the net nocicep-
tive input from the periphery to the spinal cord then on to
the brain even though the temperature applied to the par-
ticipants’ feet was the same. However, it is possible that the
positive correlation between the vlPAG connectivity and
the enhanced heat-induced CBF response of regions like
the insula, including the dorsal posterior insula (dpIns),
and SII means that the heat hyperalgesia in NP+ patients
is related to vlPAG mediated facilitation of incoming heat
input; and that cortical regions, which are known to track
key features of thermal input in healthy controls retain a
similar function in these patients (Coghill et al., 1999;
Craig et al., 2000; Segerdahl et al., 2015).
The current study provides novel insight into the multiple
ways in which the DPMS is implicated in painful DPN.
While previous work shows how DPN patients have a di-
minished capacity for descending inhibition, these data pro-
vide evidence for a parallel mechanism to be involved that
may include the vlPAG, working in conjunction with key
nodes of the DPMS (e.g. rACC, amygdala, and hypothal-
amus) to amplify pain in NP+ patients. Future work em-
ploying combined spinal-brain functional MRI will make it
possible to interrogate how these parallel processes are
related, the extent to which variability in this system may
be a useful predictor for the development of different types
of chronic pain and possibly, the extent to which this kind
of brain-based facilitation mechanism is reversible with
treatment.
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